Nanotechnologists develop a 'time bomb' to fight cardiovascular disease
Sunday, June 10, 2012 - 12:00
in Health & Medicine
Atherosclerosis, resulting in a narrowing of the arteries and the development of cardiovascular disease, is the leading cause of death worldwide. Until now, no treatment could target diseased areas exclusively, in order to increase drug efficacy and reduce side effects. To help bridge this gap, a group of Swiss researchers from UNIGE, HUG and the University of Basel have developed a veritable 'time bomb,' a treatment that can recognize the diseased areas and treat only them.